baber/WOPTO huggingface dataset:
Patent JP-2000510925-A (JP)
Title: 与圧式水洗便所洗浄装置
IPC: E03D3/10
Filed: 1998-03-05
Abstract: (57)【要約】
与圧式水洗便所操作装置は、水槽と、前記水槽にじかに載置された外部マニホールドと、内部に載置された洗浄弁組立部品とを備える。マニホールドは、水圧調整器と、空気誘導装置と、手動操作可能な洗浄弁アクチュエータとを備える。手動操作可能な洗浄弁アクチュエータは水槽からの圧力でトイレ便器への水の排出を制御する。
Patent JP-2000509420-A (JP)
Title: 有機化合物における改良または有機化合物に関連する改良
IPC: C08L77/00
Filed: 1997-05-09
Abstract: (57)【要約】
合成ポリアミドに式（Ｉ）（ここで、Ｒ 1 は、メチル基を表わす）の添加剤をそれ自体で、または安定化剤マスターバッチ組成物の形態で添加することによって、合成ポリアミドの熱安定性、光安定性、化学的安定性および染色親和性、並びに染色または着色合成ポリアミド中の着色剤の安定性および耐光性を増加させる方法。本発明による安定化剤マスターバッチ組成物は、式（Ｉ）で示される化合物および担体重合体を包含し、そして透明であることで特徴づけられる。安定化剤および着色剤マスターバッチ組成物は、さらに着色剤、すなわち色素または顔料を包含する。本発明は、前述した方法によって得ることができる、式（Ｉ）で示される化合物の安定化効果により特性が改善された改質合成ポアミドにも関する。
Patent JP-2001514658-A (JP)
Title: 異種遺伝子の一時的及び選択的発現に対する酸化ストレスを発生させる光力学的治療
IPC: A61K48/00
Filed: 1998-03-09
Abstract: (57)【要約】
本発明は異種遺伝子の選択的、一時的発現のための方法を開示している。本発明は標的組織内で異種遺伝子を選択的、一時的に発現するための方法で構成されている。加熱または光力学的治療（ＰＤＴ）によって誘発される酸化ストレスの条件下で対象の遺伝子を発現するために光力学的治療または熱によって誘発されるプロモーターが用いられる。（サイトカイン、毒素、腫瘍抑制遺伝子、アンチセンス分子、及び抗血管形成性因子などの）異種遺伝子の選択的、一時的発現は腫瘍、血管増殖、組織低酸素症の治療において有意の治療効果を有している。加熱、他の熱源（マクロ波、超音波、あるいはラジオ周波数波誘発電流など）、あるいはＰＤＴによる標的を絞った遺伝子治療は制御され、局所化された形態で治療遺伝子の発現を誘発してくれる。
Patent JP-2000510743-A (JP)
IPC: A41C1/02
Filed: 1997-05-29
Abstract: This compressive orthosis, which comprises a compressive knitted leg part (14), is characterised in that it is essentially devoid of foot and heel and in that the leg end region comprises a resilient supporting strip (16) on the malleoli (18) provided on the skin-side surface with an antiskid coating.
Patent JP-2000512490-A (JP)
IPC: C07K14/705
Filed: 1997-05-29
Abstract: The invention provides isolated human DEC-205, its extracellular domain and functionally equivalent fragments thereof. Also provided are polynucleotides encoding same and vectors which include such polynucleotides. Further provided are methods of recombinantly producing human DEC-205, an extracellular domain thereof or a functionally equivalent fragment, and ligands that bind to human DEC-205 or a fragment thereof. Also provided are constructs for use in prophylaxis or therapy comprising such a ligand, human DEC-205 or an extracellular domain thereof coupled to a toxin or to an antigen capable of inducing a protective immune response in a patient.
Patent JP-2001519804-A (JP)
IPC: A23K1/16
Filed: 1998-03-19
Abstract: Solid and non hygroscopic salts consisting of lower alkanoyl L-carnitine magnesium citrates are disclosed which are suitable for preparing solid composition useful as dietary/nutritional supplements for human use and as fodder supplement for veterinary purposes.
Patent JP-2001523121-A (JP)
IPC: A63B22/02
Filed: 1997-08-27
Abstract: Cardiopulmonary interval training between a user high target heart rate and a user low target heart rate is obtained with an exercise apparatus by increasing the load of the exercise apparatus at a first predetermined rate until either the maximum machine load is obtained or the high target heart rate. When this event occurs, the load can then be maintained at a fixed level for a predetermined time. Thereafter, the load is decreased until the low target heart rate is obtained, or the user-set exercise duration expired. The heart rate of the user is monitored during the exercise. In the event that measurement of a valid heart signal is lost at any time, any increase or decrease of the load of the exercise apparatus is terminated until a valid heart rate signal is reacquired. In the case when an exercise apparatus is a treadmill, the load can be varied by increasing or decreasing both the speed adjustment and the elevation adjustment of the treadmill. In the preferred embodiment, the speed is first adjusted until a user-set maximum speed is obtained and thereafter the elevation is adjusted in order to obtain the load variations toward or from the high and low target heart rates. The exercise may be repeated between the low and high target heart rates to provide cardiopulmonary interval training.
Patent JP-2001522463-A (JP)
Title: 微細加工光−流量ガスセンサ
IPC: G01N21/35
Filed: 1998-04-29
Abstract: (57)【要約】
高速に強度が変動または脈動する光源（１４）、干渉フィルタ（１６）、特定の波長の光または音周波数に同調された光および／または音響共振器でも、そうでなくてもよく、検出されるガスがフィルタ（２２）を介してその中に拡散することができるガス・キャビティ（２０）、および感知される特定のガスによる特定の波長での光の吸収によるガスの加熱と冷却および結果的な膨張と収縮を検出する流体または圧力センサ（１９）を有する微細加工集積光−流体または光−音響センサ（１０）。他のガスの存在が検出されたガスから推定される。
Patent NZ-195921-A (NZ)
Title: Proton-catalysed organic reaction using a layered clay as catalyst
Inventor: BALLANTINE J
IPC: B01J21/16
Filed: 1980-12-22
Abstract: The invention relates to the use of hydrogen ion-exchanged layered clays in organic reactions which are catalyzed by protons. Such organic reactions include the production of ethers by the reaction of an alcohol with an olefin or an olefin oxide, the production of an ether by the reaction of a primary or secondary aliphatic alcohol or an olefin oxide, the production of an alkyl aromatic compound by the reaction of an aromatic hydrocarbon with an olefin or a C2 or higher alcohol and the production of an alcohol by the hydration of an olefin.
Patent NZ-199644-A (NZ)
Title: Splinting bandage having hardenable isocyanate prepolymer and catalyst
Inventor: FENNIMORE J
IPC: C08G18/22
Filed: 1982-02-04
Abstract: Water hardenable splinting bandages comprising a flexible fabric carrying an isocyanate terminated prepolymer having a reaction functionality of not less than two and a catalyst which bandage is characterised in that the prepo-Iymer is a water absorbing isocyanate terminated prepolymer and the catalyst is water soluble but insoluble in the prepolymer, compositions therefore and processes of manufacture thereof are described.
Patent NZ-207671-A (NZ)
Title: Radar camouflage material
Inventor: KARLSSON L
IPC: H01Q17/00
Filed: 1984-03-28
Abstract: A radar camouflage material comprises a woven fabric (1) which incorporates metal fibrils and which is laminated with a plastics film (3) coated with a thin metal layer (4), which film is matted on its opposite side during the laminating process. The combination between the metal fibrils in the fabric and the crinkled metal layer obtained through the laminating process provides a material having good reflection properties with respect to electromagnetic radiation within a wide range of wavelengths.
Patent NZ-225152-A (NZ)
Title: Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
Inventor: VAN DAELE GEORGES HENRI PAUL
IPC: A61K31/505
Filed: 1988-06-23
Abstract: Novel N-(3-hydroxy-4-piperidinyl)substituted benzamides of formula   <CHEM>  wherein: R<1> is hydrogen, C1-6alkyl, arylC1-6alkyl, C1-6alkylcarbonyl, aminoC1-6alkyl or mono- and di(C1-6alkyl)aminoC1-6alkyl;  R<2> is hydrogen or C1-6alkyl; R<3>, R<4> and R<5> each independently are hydrogen, C1-6alkyl, C1-6alkyloxy, halo, hydroxy, cyano, nitro, amino, mono- and di(C1-6alkyl)amino, aminocarbonyl, arylcarbonylamino, C1-6alkylcarbonylamino, C1-6alkylcarbonyl, C1-6alkylcarbonyloxy, aminosulfonyl, C1-6alkylaminosulfonyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkylthio, mercapto, trifluoromethyl, arylC1-6alkyloxy or aryloxy;  Alk is a C1-6alkanediy;  X is O, S, NR<6> C(=O) or C(=S); Het is a five- or six membered heterocyclic ring being optionally fused with a six membered carbocyclic ring, and being optionally substituted; the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, which compounds are gastrointestinal motility stimulating agents; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent NZ-233180-A (NZ)
Title: Production of porous structural panels from mineral fibre or aggregate bound with resin latex and starch which comprises drying the formed panel by passing air therethrough
Inventor: IZARD DAVID GRAHAM
IPC: D21H23/04
Filed: 1990-04-03
Abstract: The manufacture of sag-resistant, lightweight structural mineral panels on a foraminous support wire (40) is accomplished by forming a dilute aqueous dispersion of mineral fiber and/or aggregate and an anionically stabilized latex binder, coupling the binder solids onto the mineral fiber materials by adding a small amount of a flocculant such as a cationic polyacrylamide, and passing the slurry onto a first flooded section (42) of the support wire (40) to form an open, entangled, structural mass having water in interstitial spaces of the entangled mass. Water is stripped from the mass and the mass dried without collapse of the open structure by passing heated dry air (50) through the open entangled structure.
Patent NZ-236631-A (NZ)
Title: Process for the preparation of a spray dried powdered pharmaceutical formulation of naproxen
Inventor: KURAMOTO ROY
IPC: A61P25/04
Filed: 1990-12-21
Abstract: The preparation of pharmaceutical powder compositions which are directly compressible into tablets, is disclosed. The disclosed process includes subjecting an aqueous slurry/solution of a pharmaceutically active drug specifically naproxen or naproxen sodium (which slurry may be directly obtained without drying from the synthesis of the drug), alone or in admixture with an aqueous mixture of excipient materials, to a controlled form of spray drying to produce a dry powder of uniform particle size wherein the drug is uniformly dispersed in and coated with the excipients. The powder can be readily combined with additional dry excipient materials and formed into tablets. The process provides for substantial savings in the manufacture of the tablets. The spray dried powder compositions are highly compressible. Utilizing such spray dried powder compositions, the tablets formed are readily dissolvable and also are stable under normal storage conditions and stress conditions of temperature and relative humidity.
Patent NZ-240357-A (NZ)
Title: Dry state iontophoresis electrodes containing non-hydrated agent and method of hydrating same
Inventor: HAAK RONALD P
IPC: A61N1/30
Filed: 1991-10-25
Abstract: A dry-state iontophoretic drug delivery device (10, 20) is provided. The device has drug and electrolyte reservoirs (15, 16) which are initially in a non-hydrated condition. In one embodiment of the invention, a passageway (21, 22) is provided through the backing layer (13) and the electrode layer (11, 12) of both the donor electrode assembly (8) and the counter electrode assembly (9). Water or other liquid can be introduced through these passageways (21, 22) in order to hydrate the drug and electrolyte reservoirs (15, 16) and activate the device (10). In another embodiment of the device (20), the drug and electrolyte reservoirs (15, 16) are initially separated from their respective electrodes (11, 12). After the reservoirs (15, 16) are hydrated, they are placed in electrical contact with their respective electrodes (11, 12). By joining the reservoir (15, 16) to the electrode (11, 12) after hydration occurs, delamination problems are reduced.
Patent NZ-242707-A (NZ)
Title: Nucleotide sequence and polypeptide of mareks disease virus and vaccine containing the polypeptide
Inventor: MORGAN ROBIN WILSON
IPC: C07K16/00
Filed: 1992-05-12
Abstract: The invention is related to a nucleic acid sequence encoding a MD06 Marek's Disease Virus protein. Such a protein can be used for the immunization of poultry against MDV infection or disease. The nucleic acid sequence encoding the MD06 MDV protein can be applied for the preparation of the protein by means of genetic engineering techniques or can be applied for the preparation of vector vaccines.
Patent NZ-248170-A (NZ)
Title: Amino-substituted thienopyridine derivatives; their preparation and medicaments
Inventor: EFFLAND RICHARD CHARLES
IPC: A61P25/26
Filed: 1993-07-16
Abstract: This application relates to compounds of the formula I <CHEM> wherein R<1>, R<2>, R<3>, m and n are as defined in the specification which are useful as modulators of neurotransmitter function such as serotonergic and adrenergic, and as such are useful as antidepressants, anxiolytics, atypical antipsychotics, antiemetics, and for the treatment of personality disorders such as obsessive compulsive disorders. Certain of the compounds are also useful as glycine partial agonists. The application relates also to a process for the preparation of the compounds of formula I.
Patent NZ-264779-A (NZ)
Title: Telecommunication plug/socket two part coupling unit
Inventor: JACKSON SIMON
IPC: H01R4/24
Filed: 1994-10-26
Abstract: A termination unit for telecommunication and data lines, including a front portion provided with an insertion opening, a frame, an electrical plug connector, a plug socket and contact elements for the lines. In order to simplify accessibility to the electrical plug connector of the termination unit, the front portion is adapted as one piece together with the frame and is provided with a removable access cover and that the electrical plug connector and the plug socket are disposed on the rear side of the removable access cover behind the insertion opening of a component unit disposed on the rear side of the front portion and connected to the plug connector with the plug socket.
Patent NZ-268957-A (NZ)
Title: Method and kit for the detection, identification and/or quantification of a target bacteriophage
Inventor: SANDERS MICHAEL FREDERICK
IPC: C12Q1/04
Filed: 1994-07-29
Abstract: PCT No. PCT/GB94/01649 Sec. 371 Date Feb. 7, 1996 Sec. 102(e) Date Feb. 7, 1996 PCT Filed Jul. 29, 1994 PCT Pub. No. WO95/05483 PCT Pub. Date Feb. 23, 1995A method for detection, identification and/or quantification of bacteriophage of bacterial host specificity for bacterial genus, species or serotype, based upon the occurrence of release of cell contents, particularly nucleotides e.g. ATP, on lysis of bacterial cell walls on incubation with bacterial host cells. When new phage particles are released at the end of the phage replication cycle nucleotide levels are measured and compared with controls. The method provides for the detection of specific phages which is faster and more sensitive than known techniques. The method is only limited by the availability of host bacteria/target phage pairings.
Patent NZ-281462-A (NZ)
Title: Intervertebral fusion implant comprising two spaced apart, parallel bearing surfaces
Inventor: KOHRS DOUGLAS W
IPC: A61F2/46
Filed: 1995-02-09
Abstract: An implant for use in spinal stabilization includes four generally linear thread segments. The thread segments are maintained and spaced apart alignment by rigid supports. The thread segments include a plurality of individual threads with the individual threads of the segments defining a thread pattern. The supports and the thread segments define a hollow implant interior exposed to an exterior of the implant.
Patent NZ-334617-A (NZ)
Title: Conference calling system for digital wireless phone network using variable rate vocoded signals
Inventor: KIMBALL ROBERT H
IPC: H04W88/02
Filed: 1997-09-11
Abstract: A conference calling system for a wireless communications channel. The system is adapted for use with a channel having first, second and third participants communicating via first, second and third transmitters and receivers respectively. The system includes a circuit for receiving an encoded signal from at least one of the transmitters. A second circuit determines which of the participants is speaking from the received encoded signal. A third circuit is provided for re-transmitting an encoded signal received from the speaking participant to the other participants. In the illustrative implementation, the encoded signals are variable rate speech vocoded signals in which speech is vocoded at full rate, silence is vocoded at +E,fra 1/8+EE th rate and the +E,fra 1/2 +EE  and +E,fra 1/4+EE  rates are used as transitional rates. In the illustrative implementation, the speaker's signal is identified by examining the rate of the received vocoded signals. When the speaker's vocoded signal is identified, it is re-transmitted without de-vocoding to the non-speaking participants in the conference call. By re-transmitting the speaker's signal without de-vocoding, the quality of the received signal is preserved.
Patent NZ-501832-A (NZ)
Title: Angiotensin-peptide carrier conjugates for treating diseases associated with the renin-angiotensin system
Inventor: GLOVER JAMES FRANCIS
IPC: A61K47/48
Filed: 1998-06-23
Abstract: The use of an immunogenic angiotensin conjugate comprising at least one angiotensin I peptide moiety or a functional equivalent thereof coupled via a peptide carrier-binding moiety to a carrier for the manufacture of a medicament for use in combatting diseases associated with the rennin-angiotensin system.
Patent NZ-503395-A (NZ)
Title: A test circuit characterised by an in-built diagnostic system where the circuit is connected in parallel with a current loop where a test current is injected and is superimposed on either the sensor or acquisition current loop
Inventor: AUDREN JEAN-PAUL
IPC: G08C19/02
Filed: 1999-07-19
Abstract: The 4 mA-20 mA type or 0-20 mA type current loop connects an analog sensor (1) to an acquisition system (3), respectively carrying a sensor current (Ic) and an acquisition current (Ia). A test circuit is connected in parallel with the current loop to inject a superposition current (Is) in the loop. The current is superposed on the sensor current (Ic) or on the acquisition current (Ia). In the first embodiment, a variable voltage generator (7) injects the superposition current (Is) by adding it to the acquisition (Ia), thereby making it possible to check a low current threshold of the acquisition system (3). In the second embodiment, a variable current regulator injects the superposition current (Is) by adding it to the sensor current (Ic), thereby making it possible to check a high current threshold of the acquisition system. The high and low current thresholds of the acquisition system are tested without opening the current loop.
Patent NZ-504991-A (NZ)
Title: Pharmaceutical compositions containing micronized benzopyran or pyridopyran derivatives, and their use as medicaments
Inventor: KNIGHT WENDY ANNE
IPC: A61P25/28
Filed: 1998-12-14
Abstract: Pharmaceutical composition comprising a compound of Formula I or Formula II in particulate form, the composition having a particle size distribution such that the median value of the volume mean diameter is within the range of from 350 to 700 nm. The compound of formula I is defined as follows: either Y is N and R2 is hydrogen, or Y is C-R1 where: either one of R1 and R2 is hydrogen and the other is hydrogen, cycloalkyl, alkyl optionally interrupted by O or substituted by hydroxy, alkoxy or substituted aminocarbonyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, alkoxy, nitro, cyano, halo, trifluoromethyl, CF3S, or a group CF3-A-, where A is -CF2-, -CO-, -CH2-or CH (OH), trifluoromethoxy, alkylsulphinyl, alkylsulphonyl, alkoxysulphinyl, alkoxysulphonyl, aryl, heteroaryl, arylcarbonyl, heteroarylcarbonyl, arylsulphinyl, heteroarylsulphinyl, arylsulphonyl, heteroarylsulphonyl in which any aromatic moiety is optionally substituted, alkylcarbonylamino, alkoxycarbonylamino, alkyl-thiocarbonyl, alkoxy-thiocarbonyl, alkyl-thiocarbonyloxy, 1-mercaptoalkyl, formyl, or aminosulphinyl, aminosulphonyl or aminocarbonyl, any amino moiety being optionally substituted by one or two alkyl groups, or alkylsulphinylamino, alkylsulphonylamino, alkoxysulphinylamino or alkoxysulphonylamino, or ethylenyl terminally substituted by alkylcarbonyl, nitro or cyano, or -C(alkyl)NOH or -C(alkyl)NNH2, or one of R1 and R2 is nitro, cyano or alkylcarbonyl and the other is methoxy or amino optionally substituted by one or two alkyl or by alkanoyl; one of R3 and R4 is hydrogen or alkyl and the other is alkyl; or R3 and R4 together are polymethylene; R5 is alkylcarbonyloxy, benzoyloxy, ONO2, benzyloxy, phenyloxy or alkoxy and R6 and R9 are hydrogen or R5 is hydroxy and R6 is hydrogen or alkyl and R9 is hydrogen; R7 is fluorophenyl; R8 is hydrogen or alkyl; the R8-N-CO-R7 group being trans to the R5 group; and X is oxygen or NR10 where R10 is hydrogen or alkyl ; The compound of formula II is defined as follows: Definitions of variables Y and X, R5, R6, R9 are the same as for the compound of formula I. R1 and R2 are defined as for formula (I) except for the following additional options: One of R1 and R2 is H and the other is CF3-A, where A may additionally be SO2, SO, CH2-O, or CONH; or one of R1 and R2 is H and the other is the group CF2H-A'- where A' is O, S, SO, SO2, CF2 or CFH; or R1 and R2 together may form -(CH2)4 - or -CH = CH-CH = CH-; or R1 and R2 may form together an optionally substituted triazole or oxadiazole ring. One of R3 and R4 is hydrogen and the other is alkyl, CF3 or CH2Xa; or R3 and R4 together are polymethylene optionally substituted by alkyl. R7 is optionally substituted heteroaryl or phenyl. R8 is hydrogen, alkyl, OR9 or NHCOR10, the R8-N-CO-R7 group being cis to the R5 group The composition described above is useful for the treatment of nervous system disorders.
Patent NZ-506248-A (NZ)
Title: Method and device for forming a socket on a pipe of thermoplastic material
Inventor: HUTCHINSON WILLIAM GEORGE
IPC: B29B13/02
Filed: 1999-02-16
Abstract: Method for forming a socket on a pipe of thermoplastic material.   In the process, an end section, to  be  provided with  a  socket, of the pipe is heated in a heating station. Then,  the  pipe with the heated end section is  transferred to  a  socket-forming station (30) which comprises a socket- forming  mandrel (40), the socket-forming station being  set up in such a way that a pipe can therein be provided with  a socket,   while  the  end  section  of  another   pipe   can simultaneously  be heated in the heating  station.  This  is followed   by   the   socket-forming  mandrel   (40)   being introduced  into the pipe end section, heated to a  suitable socket-forming  temperature,  and  the  end  section   being formed  into  a socket. Prior to the pipe end section  being heated  in  the heating station, a support (3) is introduced into the end section of the pipe, said support extending  at least  over  the  length  of the end  section  in  order  to internally support the end section. When the pipe  with  the heated  end  section  is transferred to  the  socket-forming station, this support (3) remains in the end section,  after which  the  socket-forming mandrel (40) is  introduced  into the  pipe  and  in  the process the support  (3)  is  pushed deeper into the pipe (1).
Patent NZ-506987-A (NZ)
Title: Nucleic acid binding proteins
Inventor: CHOO YEN
IPC: C07K14/47
Filed: 1999-03-17
Abstract: A method for producing a zinc finger polypeptide which binds to a target nucleic acid sequence containing a modified base but not to an identical sequence containing an equivalent unmodified base.
Patent NZ-508817-A (NZ)
Title: Flexible structure comprising starch filaments
Inventor: TROKHAN PAUL DENNIS
IPC: D04H1/4274
Filed: 2000-12-12
Abstract: A flexible structure comprising a plurality of starch filaments, the structure comprising at least a first region and a second region, each of the first and second regions having at least one common intensive property selected from the group consisting of density, basis weight, elevation, opacity, crepe frequency, and any combination thereof, wherein at least one common intensive property of the first region differs in value from at least one common intensive property of the second region.
Patent NZ-512476-A (NZ)
Title: Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
Inventor: KENNEDY THOMAS J
IPC: A61P15/06
Filed: 1999-12-17
Abstract: A method for therapeutically treating a non-human animal suffering from parasitic neurologic or abortigenic disease which is susceptible to treatment with a triazineone compound, with the proviso that when the disease is Sarcocystis neurona the compound is not diclazuril, toltrazuril, clazuril or letrazuril.